Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 5/1998

01-09-1998 | Correspondence

Acute hepatitis in a patient treated with saquinavir and ritonavir: Absence of cross-toxicity with indinavir

Authors: B. Vandercam, M. D., M. Moneau, M. D., C. Horsmans, M. D., Ph. D., J. L. Gala, M. D., Ph. D.

Published in: Infection | Issue 5/1998

Login to get access
Metadata
Title
Acute hepatitis in a patient treated with saquinavir and ritonavir: Absence of cross-toxicity with indinavir
Authors
B. Vandercam, M. D.
M. Moneau, M. D.
C. Horsmans, M. D., Ph. D.
J. L. Gala, M. D., Ph. D.
Publication date
01-09-1998
Publisher
Urban & Vogel
Published in
Infection / Issue 5/1998
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/BF02962257

Other articles of this Issue 5/1998

Infection 5/1998 Go to the issue

Clinical and Epidemiological Studies

Bioelectrical impedance analysis predicts outcome in patients with suspected bacteremia

Correspondence

Treatment of cryptococcal meningitis in liver transplantation

Special Addendum—Part I

Culture of human peritoneum—A new method to measure the local cytokine response and the effect of immunomodulators

Correspondence

Seroprevalence of hepatitis B infection in Turkish children

Correspondence

Safety of tetanus vaccination in relapsing-remitting multiple sclerosis

Clinical and Epidemiological Studies

Human but not ovine isolates ofBordetella parapertussis are highly clonal as determined by PCR-based RAPD fingerpringting
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits